4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-23-027587
Chief Financial Officer gave up 3,444 shares (to pay taxes)
- Chief Financial Officer acquired 9,956 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tsuchimoto Kim R Chief Financial Officer | 2023-09-30 | Option exercise | +9,956 | 41,430 | D | ||
| Tsuchimoto Kim R Chief Financial Officer | 2023-09-30 | Shares withheld for taxes | −3,444 | $0.62 | $2,135 | 37,986 | D |
| Derivatives | |||||||
| Tsuchimoto Kim R Chief Financial Officer | 2023-09-30 | Option exercise · Restricted Stock Units | −9,956 | 105,513 | D | ||
Loading xslF345X05/rdgdoc.xml…